RankAlpha logo
Back to Rankings

DTIL

Precision BioSciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The Q2 update improved the scientific narrative through initial clinical evidence of direct cccDNA elimination, while active DMD recruitment and runway through 2028 provide multiple potential year-end validation points.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +10.6.
What can break
Early clinical evidence is based on limited patient-level biopsy data and remains subject to durability, safety, and reproducibility risk.
Momentum
52
Value
41
Sentiment
74
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.50 · Bull $12.00 · Bear $4.50Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $29.40
Why
Momentum52 · Δ7d -14.0
Value41 · Δ7d 0.0
Sentiment74 · Δ7d +10.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite, 7D delta +10.6.

Contradictions & invalidation

  • • Early clinical evidence is based on limited patient-level biopsy data and remains subject to durability, safety, and reproducibility risk.
  • • FUNCTION-DMD recruitment and year-end data delivery may be delayed or produce insufficient efficacy evidence.
  • • Both programs remain early-stage and data-limited.

Catalyst clock

2026-12-31

Q2 update strengthens HBV clinical proof point

Lead driver: Sentiment · See AI snapshot
Momentum
52
9% active weight
Current posture
7d trendSoftening
Δ7d
-14.0
Δ21d
+11.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
74
62% active weight
Current posture
7d trendImproving
Δ7d
+10.6
Δ21d
+15.8
Why this grade

Composite grade B. Momentum 52.2 / Value 41.2 / Sentiment 74.2

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method

B+
Bull case
25%
Probability
Target price
$12.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$204.25M
Beta
1.31
Shares Out
27.6M
P/E (TTM) · Derived
-2.0
P/S (TTM)
133.84
P/FCF (TTM) · Derived
-2.82
Rev YoY
-100.0%
EPS YoY
-40.7%
Gross Margin
+94.2%
Op Margin
-86.8%
Net Debt
-$86.78M
Current Ratio
12.82
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data